Cargando…
RICH1 inhibits breast cancer stem cell traits through activating kinases cascade of Hippo signaling by competing with Merlin for binding to Amot-p80
Cancer stem cells (CSCs) are regarded as the root of tumor recurrence and distant metastasis, as well as the major cause of resistance to conventional cancer therapies. Elucidating the mechanism of regulating CSCs is of great significance for the development of CSCs-targeting therapy strategies. YAP...
Autores principales: | Tian, Qi, Gao, Huan, Zhou, Yan, Zhu, Lizhe, Yang, Jiao, Wang, Bo, Liu, Peijun, Yang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782888/ https://www.ncbi.nlm.nih.gov/pubmed/35064101 http://dx.doi.org/10.1038/s41419-022-04516-2 |
Ejemplares similares
-
Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway
por: Li, Youjun, et al.
Publicado: (2015) -
Hippo Pathway Phylogenetics Predicts Monoubiquitylation of Salvador and Merlin/Nf2
por: Wisotzkey, Robert G., et al.
Publicado: (2012) -
DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins
por: Nguyen, Hung Thanh, et al.
Publicado: (2017) -
Activation mechanisms of the Hippo kinase signaling cascade
por: Bae, Sung Jun, et al.
Publicado: (2018) -
Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling
por: Kim, Soyoung, et al.
Publicado: (2016)